Preston Klassen

Preston Klassen is a declared insider at 3 companies (chief executive); the most frequent names are Metacrine, Inc., Regulus Therapeutics Inc. and Orexigen Therapeutics, Inc. The record holds 12 filings, for trades running from 30 May 2015 to 25 June 2025.

On the open market, the record shows 2 purchases worth €145k and 3 sales worth €203k. On balance, insiders were net sellers of €58k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 6 share grants. In 2025 alone, the filings show 1 purchase and 1 sale.

Most recently, on 27 June 2025, the filings show a transaction in Regulus Therapeutics Inc. The latest purchase dates back some time: it was published 501 days ago, on 4 June 2025. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.